ABOUT USSOLUTIONESGINVESTORSMEDIA
CONTACTCAREERS
CONTACT
About Us
SOLUTION
ESG
INVESTORS
MEDIA
咨询事项CAREERS
한국어English
汉语(简体)
漢語(繁體)

Governance

实践“董事会中心经营模式”，提高企业价值与股东价值。
董事会
监事会
股东大会

董事会

HUGEL积极实践“董事会中心经营模式”，以强化社会责任经营、提升企业价值和股东价值。
拥有独立性、专业性以及多样性的HUGEL董事会支持管理层的合理、透明的决策。

董事会的独立性、专业性与多样性

HUGEL董事会于2022年7月决定分离代表执行董事和董事长的职务，由其他非执行董事担任董事长职务，以确保董事会运作的独立性，进一步提高监督工作的透明性。内部董事在各领域具备专业知识，并负责企业的整体运营。

董事会结构

截至2024年3月底，董事会共由7名董事组成（5名其他非常务董事、2名外部董事）。董事会就法律法规或章程规定的事项、股东大会的委任事项以及公司经营的基本方针和重要工作事项进行决议，并确保制度性机制，以保证合理决策和透明经营。

董事会

Title
Name
POSITION
Term
TITLE
NAME · POSITION · TERM
Non-executive Director
Suk-yong Cha
Chair of the Board of Directors,
Non-executive Director
Mar. 2023~Mar. 2026
Non-executive Director
Jon Huh
Non-executive Director
Mar. 2025~Mar. 2028
Non-executive Director
Michael Keyoung
Non-executive Director
Apr. 2025~Apr. 2028
Non-executive Director
Ki Chul Cho
Non-executive Director
Mar. 2024~Mar. 2027
Independent Director
Seungmin Chee
Chair of the Audit Committee, 
Non-executive Director
Apr. 2025~Apr. 2028
Non-executive Director
Taehyoung Lee
Member of the Audit Committee,
Non-executive Director
Apr. 2025~Apr. 2028
Independent Director
Patrick Holt
Member of the Audit Committee,
Independent Director
Apr. 2025~Apr. 2028

董事会活动

2024
2023
2022
2021
Date · Agenda
Date
Agenda
STATUS
ATTN
2024.12.05
Agenda 1: Trust Agreement for Treasury Stock Acquisition
Approved
7/7
2024.11.06
Report 1: Financial Statements for Q3 2024
Agenda 1: Decision on the Method of Exercising Stock Options
Agenda 2: Cancellation of stock option grants
Agenda 3: Approval of new facility installation
Agenda 4: Granting of Stock Options
Agenda 5: Payment of Performance Bonuses
Reported
Approved
Approved
Approved
Approved
Approved
7/7
7/7
7/7
7/7
7/7
7/7
2024.08.27
Agenda 1: Cancellation of Decision on the Stock Option Exercising Method
Agenda 2: Decision on the Method of Exercising Stock Options
Approved
Approved
7/7
7/7
2024.08.07
Report 1: Financial Statements for Q2 2024
Agenda 1: Relocation of the headquarters
Agenda 2: Appointment of Chief Compliance Officer
Agenda 3: Decision on the Method of Exercising Stock Options
Agenda 4: Cancellation of Stock Option Grants
Reported
Approved
Approved
Approved
Approved
7/7
7/7
7/7
7/7
7/7
2024.05.08
Report 1: Financial Statements for Q1 2024
Agenda 1: Decision on the Method of Exercising Stock Options
Reported
Approved
7/7
7/7
2024.03.27
Agenda 1: Trust Agreement for Treasury Stock Acquisition
Approved
7/7
2024.03.14
Report 1: Evaluation on the Audit Committee's Internal Accounting Control System Operation
Report 2: The Audit Committee’s 23rd term (for 2023) Report Submission
Agenda 1: Approval of the 2024 Business Plans
Agenda 2: Convening of the 23rd Annual General Shareholders' Meeting
Agenda 3: Decision on the Method of Exercising Stock Options
Reported
Reported
Approved
Approved
Approved
7/7
7/7
7/7
7/7
7/7
2024.02.13
Report 1: Financial Statements for Q4 2023
Report 2: Operation of the Internal Accounting Control System
Report 3: Operation of the Compliance Control System
Agenda 1: Approval of the 23rd Term (for 2023) Financial Statements
Agenda 2: Approval of the 23rd Term (for 2023) Sales Report
Agenda 3: Approval of the 2024 Occupational Safety and Health Business Plan
Agenda 4: Cancellation of Stock Option Grants
Agenda 5: Trust Agreement for Treasury Stock Acquisition
Reported
Reported
Reported
Approved
Approved
Approved
Approved
Approved
5/7
5/7
5/7
5/7
5/7
5/7
5/7
5/7
Date · Agenda
Date
Agenda
STATUS
ATTN
2023.12.22
Agenda 1 : Cancellation of Treasury Shares
Approved
4/7
2023.11.13
Report 1 : Report of the Year 2023 3Q Financial Statement
Agenda 1 : Treasury Stock Acquisition Trust Agreement
Reported
Approved
6/7
6/7
2023.09.08
Agenda 1 : Stock Acquisition Agreement for subsidiary Hugel America
Agenda 2 : Monetary Loan to subsidiary Hugel America
Approved
Approved
7/7
7/7
2023.08.09
Report 1 : Report of the Year 2023 2Q Financial Statement
Agenda 1 : Appointment of executive officers
Agenda 2 : Appointment of Representative Executive Officer
Reported
Approved
Approved
5/7
5/7
5/7
2023.07.14
Agenda 1 : Proposal to extend the maturity and conversion period of the 2nd unsecured private convertible bonds
Approved
4/7
2023.07.05
Agenda 1 : Proposal to convene a meeting of bondholders for the 2nd unsecured private convertible bonds
Approved
4/7
2023.05.09
Report 1 : Report of the Year 2023 1Q  Business Performance
Report 2 : Report of the Year 2023 1Q Financial Statement
Reported
Reported
7/7
7/7
2023.03.30
Agenda 1 : Appointment of  Chairman of the Board
Agenda 2 : Approval for granting stock purchase options
Agenda 3 : Approval of large-scale internal transactions
Agenda 4 : Proposal for cancellation of the grant of stock purchase options
Approved
Approved
Approved
Approved
7/7
7/7
7/7
7/7
2023.03.09
Report 1 : Report of internal accounting management system evaluation by the Audit Committee
Report 2 : Submission of the audit report for the 22nd term (2022.01.01~2022.12.31) by the Audit Committee
Agenda 1: Proposal to convene the 22nd regular shareholders' meeting
Agenda 2 : Appointment of Executive Officers
Agenda 3 : Proposal for investment in Hugel America
Agenda 4 : Proposal for the method of exercising stock purchase options
Reported
Reported
Approved
Approved
Approved
Approved
7/7
7/7
7/7
7/7
7/7
7/7
2023.02.14
Report 1 : Report of the evaluation of the internal accounting management system
Report 2 : Report of the evaluation of the compliance control system
Report 3 : Report of the subsidiary's delegated decision-making policy
Report 4 : Report of the 2022 KPI performance and 2023 goals
Agenda 1 : Approval of the 22nd (2022.01.01~2022.12.31) Financial Statement
Agenda 2 : Approval of the 22nd (2022.01.01~2022.12.31) Business Report
Agenda 3 : Approval of the 2023 business plan
Agenda 4 : Treasury Stock Acquisition Trust Agreement
Agenda 5 : Approval of the 2023 occupational safety and health business plan
Reported
Reported
Reported
Reported
Approved
Approved
Approved
Approved
Approved
7/7
7/7
7/7
7/7
7/7
7/7
7/7
7/7
7/7
Date · Agenda
Date
Agenda
STATUS
ATTN
2022.11.09
Report 1 : Progress schedule of investment in Hugel America
Agenda 1 : Proposal for the establishment and investment in overseas subsidiaries
Agenda 2 : Approval of concurrent directorship
Agenda 3 : Approval of the grant of stock purchase options
Agenda 4 : Approval of large-scale internal transactions
Agenda 5 : Cancellation of the grant of stock purchase options
Agenda 6 : Termination of the Meditech business
Reported
Approved
Approved
Approved
Approved
Approved
Approved
7/7
7/7
7/7
7/7
7/7
7/7
7/7
2022.09.20
Agenda 1 : Proposal to set the record date for the extraordinary shareholders' meeting
Agenda 2 : Proposal to convene the extraordinary shareholders' meeting
Agenda 3 : Treasury Stock Acquisition Trust Agreement extension
Approved
Approved
Approved
7/7
7/7
7/7
2022.08.10
Report 1 : Progress schedule for the approval of granting stock purchase options
Reported
7/7
2022.07.01
Agenda 1 : Appointment of  Chairman of the Board
Approved
7/7
2022.05.19
Agenda 1 : Proposal to convene the extraordinary shareholders' meeting
Agenda 2 : Proposal for setting the record date
Agenda 3 : Approval of adopting electronic voting
Approved
Approved
Approved
7/7
7/7
7/7
2022.04.14
Agenda 1 : Proposal to convene the extraordinary shareholders' meeting
Agenda 2 : Proposal for the division and purchase of convertible bonds
Approved
Approved
5/6
5/6
2022.04.07
Agenda 1 : Treasury Stock Acquisition Trust Agreement
Approved
5/6
2022.03.08
Report 1 : Report of internal accounting management system evaluation by the Audit Committee
Report 2 : Submission of the audit report for the 21st term (2021.01.01~2021.12.31) by the Audit Committee
Agenda 1 : Amendment of executive compensation regulations
Agenda 2 : Amendment of executive severance
Agenda 3 : Proposal to convene the 21st regular shareholders' meeting
Agenda 4 : Proposal to amend the record date for the extraordinary shareholders' meeting
Agenda 5 : Cancellation of granting stock purchase options
Reported
Reported
Approved
Approved
Approved
Approved
Approved
6/7
6/7
6/7
6/7
6/7
6/7
6/7
2022.02.10
Report 1 : Report of internal accounting management system evaluation
Agenda 1 : Approval of the 21st(2021.01.01~2021.12.31) Financial Statement
Agenda 2 : Approval of the 21st(2021.01.01~2021.12.31) Business Report
Agenda 3 : Liquidation of the Weihai Subsidiary
Agenda 4 : Liquidation of the Vietnam Subsidiary
Reported
Approved
Approved
Approved
Approved
6/7
6/7
6/7
6/7
6/7
2022.01.17
Agenda 1 : Proposal to set the record date for the extraordinary shareholders' meeting
Approved
7/7
Date · Agenda
DATE
AGENDA
STATUS
ATTN
2021.12.16
Agenda 1 : Proposal for setting the dividend record date
Approved
7/7
2021.12.13
Agenda 1 : Treasury Stock Acquisition Trust Agreement
Agenda 2 : Cancellation of Treasury Shares
Approved
Approved
6/7
6/7
2021.10.01
Agenda 1 : Proposal to set the record date for the extraordinary shareholders' meeting
Approved
6/7
2021.09.09
Agenda 1 : Treasury Stock Acquisition Trust Agreement extension
Approved
5/7
2021.04.08
Agenda 1 : Proposal for the method of exercising stock purchase options
Agenda 2 : Proposal for the transfer and cancellation/settlement of real estate contracts
Approved
Approved
7/7
7/7
2021.03.26
Agenda 1 : Reappointment of Co-Chairs of the Board
Agenda 2 : Appointment of Executive Directors
Approved
Approved
7/7
7/7
2021.03.10
Report 1 : Report of internal accounting management system evaluation by the Audit Committee
Report 2 : Submission of the audit report for the 20th term by the Audit Committee
Agenda 1 : Treasury Stock Acquisition Trust Agreement
Reported
Reported
Approved
7/7
7/7
7/7
2021.02.09
Report 1 : Report of internal accounting management system evaluation
Agenda 1 : Approval of the 20th (2020.01.01~2020.12.31) Financial Statement
Agenda 2 : Approval of the 20th (2020.01.01~2020.12.31) Business Report
Agenda 3 : Proposal to convene the 20th regular shareholders' meeting
Agenda 4 : Establishment of  the Compliance Control System
Agenda 5 : Appointment of Compliance Support Personnel
Reported
Approved
Approved
Approved
Approved
Approved
7/7
7/7
7/7
7/7
7/7
7/7

监事会

HUGEL基于公司章程第四十一条第二款的条例成立并运营监事会。截至2024年12月底，监事会监事共有三人，由2名外部董事和1名其他非执行董事组成。监事会监事可以出席董事会会议，独立监督董事的相关业务，并在与公司业务相关的事项上要求相关部门提交相关账本和文件。此外，必要时也可以要求公司告知相关经营事项，并以适当的方式获取经营信息。

监事会结构

Title · Name
Careers
Relationships with Shareholders
Term
TITLE · NAME · Careers · TERM
Audit Committee Chair
Seungmin Chee
• Ph.D. in Business Administration from the University of California at Berkeley
• Assistant Professor at the University of Oregon, Eugene
• Member of the Accounting System Deliberation Committee of the Securities and Futures Commission
• Non-executive Director at Korea Institute of Marine Science & Technology Promotion
• Associate Professor at  Korea University Business School
• Certified Public Accountant
- Certified Public Accountant, Deloitte Anjin Accounting Corporation (98.11~00.04, 03.02~03.09)
- Academic Director, Korean Accounting Association (2016~2017, 2018~2019)
- Editorial Board Member, Korean Accounting Association (2020-2021)
- Editorial Board Member, Korean Securities Association (2021-present)
None
Apr. 2025 ~ Apr. 2028
Audit Committee Member
Patrick Holt
• Bachelor's degree in Biochemistry from Monash University
• President Director, Merck & Co., Inc.
• Vice President, Allergan Inc.
• Non-Executive Director, Ascenda Loyalty
• President, Cordis(Cardinal Health Inc.)
None
Apr. 2025 ~ Apr. 2028
Audit Committee Member
Taehyoung Lee
• University of Washington MBA
• CEO, Incheon Total Energy Company
• Executive Vice President and Head of the Management Planning Division, GS Energy Co., Ltd.
• CFO, PM Team Leader, and Executive Vice President, GS Corporation
None
Apr. 2025 ~ Apr. 2028

监事会活动

2024

DATE · AGENDA
DATE
Agenda
STATUS
2024.11.05
Agenda 1: Approval of the Q3 2024 Financial Statement
Approved
2024.08.06
Agenda 1: Approval of the Q2 2024 Financial Statement
Approved
2024.05.07
Agenda 1: Approval of the Q1 2024 Financial Statement
Approved
2024.03.12
Agenda 1:  Confirmation of the Internal Accounting Management System Evaluation Report
Agenda 2: Submission of the Audit Committee's Opinion on Internal Monitoring Mechanisms
Agenda 3: Confirmation of the Audit Report for the 23rd Term (Fiscal Year of 2023) by the Audit Committee
Agenda 4: Review of the Legality of Agendas and Documents for the 23rd Annual Shareholders' Meeting
Approved
Approved
Approved
Approved
2024.02.13
Report 1: Report on Internal Accounting Management System Operations
Report 2: Approval of the 23rd (2023.01.01~2023.12.31) Financial Statement
Report 3: Approval of the 23rd (2023.01.01~2023.12.31) Sales Report
Report 4: Results of Periodic Designation of External Auditors
Reported
Reported
Reported
Reported

2023

DATE · AGENDA
DATE
Agenda
STATUS
2023.02.14
Report 1 : Report of internal accounting management system evaluation
Report 2 : Approval of the 22nd (2022.01.01~2022.12.31) Financial Statement
Report 3 : Approval of the 22nd (2022.01.01~2022.12.31) Business Report
Report 4 : Report of the periodic auditor designation results by external auditors
Reported
Reported
Reported
Reported
2023.03.08
Report 1 : Report of internal accounting management system plan for 2023
Agenda 1 : Approval of the internal accounting management system evaluation
Agenda 2 : Submission of the Audit Committee's opinion on internal monitoring mechanisms
Agenda 3 : Confirmation of the audit report for the 22nd term (2022 fiscal year) by the Audit Committee
Agenda 4 : Review of the legality of agendas and documents to be submitted to the 22nd regular shareholders' meeting
Reported
Approved
Approved
Approved
Approved
2023.05.09
Agenda 1 : Approval of the Year 2023 1Q Financial Statement
Approved
2023.08.08
Report 1 : Improvement measures of accounting system of the Financial Services Commission
Agenda 1 : Approval of the Year 2023 2Q Financial Statement
Reported
Approved
2023.11.07
Report 1 : Report of the management issues for the third quarter
Agenda 1 : Approval of the Year 2023 3Q Financial Statement
Reported
Approved

股东大会

2025

DATE · AGENDA
DATE
AGENDA
STATUS
The 24th Annual Meeting of Shareholders (2025.03.31)
1. Approval of the 24th Financial Statement
2. Appointment of Board Directors (Three Non-Executive Directors and One External Director)
3. Appointment of External Director Seungmin Chee as Audit Committee Member
4. Appointment of Two Members of Audit Committee
5. Approval of Compensation Limits for Directors
6. Approval of Granting of Stock Options
Approved
Approved
‍
Approved
‍
Approved
Approved
Approved

2024

DATE · AGENDA
DATE
AGENDA
STATUS
The 23rd Annual Meeting of Shareholders (2024.03.29)
1. Approval of the 23rd financial statements
2. Appointment of Directors (1 Non-Executive Director)
3. Approval of director remuneration limit
Approved
Approved
Approved

2023

DATE
AGENDA
STATUS
DATE · AGENDA
The 22nd Annual Meeting of Shareholders (2023.03.30)
1. Approval of the 22nd Financial Statement
2. Appointment of Directors (1 Non-Executive Director)
3. Approval of granting stock options
4. Approval of director remuneration limit
Approved
Approved
Approved
Approved

2022

DATE · AGENDA
DATE
AGENDA
STATUS
The 21st Annual Shareholders’ Meeting (2022.03.25)
1. Approval of the 21st Financial Statement
2. Approval of director remuneration limit
3. Amendment of executive severance
Approved
Approved
Approved
The 22nd Extraordinary Shareholders' Meeting (2022.04.29)
1. Appointment of Directors (4 Non-Executive Directors, 1 Independent Director)
2. Appointment of independent director, Seungmin Chee to a member of the Audit Committee
3. Appointment of the Audit Committee members
Approved
‍
Approved
‍
Approved
The 22nd Extraordinary Shareholders' Meeting (2022.06.29)
1. Appointment of Directors (1 Non-Executive Director)
‍
‍
Approved

‍
The 22nd Extraordinary Shareholders' Meeting (2022.10.28)
1. Amendment of Articles of Incorporation
2. Approval of granting stock purchase options
Approved
Approved
+

ESG

HUGEL秉持绿色经营，积极履行社会责任，基于透明公正的支配结构，引领实现可持续性美好生活。

+

ENVIRONMENTAL

HUGEL秉持绿色经营，积极履行社会责任，基于透明公正的经营结构，引领实现可持续性美好生活。

+

SOCIAL

HUGEL遵循注重人类尊严与价值的平等经营，积极履行社会责任，与所有员工、合作伙伴、地方社会等所有相关方共同追求可持续增长。

HUGEL
总部和巨头工厂和研究所 | 江原特别自治道东内面巨头园地1路23 | Tel. 033-815-5200
首尔地址 | 首尔特别市江南区三成路133路17 | Tel. 02-6966-1600
© 2024 HUGEL, Inc. All rights reserved.
使用条款
ㅣ
法律声明
ㅣ
个人信息处理指南
FAMILY SITES